NHS England is rolling out the one-off injection medication, nirsevimab, from late September to provide protection against RSV for eligible high-risk and very preterm babies who are born too early to ...

For births that occur within an NHS trust and/or with private health providers – whether in a hospital setting or at home with the support of a registered midwife – birth notifications are processed ...

The approval for running MARS in the NHS trusts, foundation trusts and ICBs, is delegated to DHSC, by HM Treasury, annually (for each financial year). Each MARS is required to adhere to national model ...

If you are unable to notify within 36 hours (for example, due to an emergency), you must do so as soon as possible. If it is more than 36 hours since the birth, please contact ...

John Stewart, National Director for Specialised Commissioning, said: “Since 2019, thousands of people with cystic fibrosis have been able to benefit from licensed treatments – firstly Orkambi® and ...

Early data indicates that less than a third of resident doctors chose to strike with the number of strikers down by 7.5% (1,243) compared to the previous round of industrial action with most resident ...

NHS England » General Practice Forward ViewHome General practice General Practice Forward View General Practice Forward View The General Practice Forward View (GP Forward View), was published in April ...

NHS England » Improving wheelchair servicesHome Improving wheelchair services Improving wheelchair services NHS England support integrated care boards (ICBs) to commission effective, efficient and ...

The letter sets out the financial implications of these decisions, details of the additional funding allocations issued in Month 4 and the actions required of integrated care boards (ICBs).

Organ transplants not only save lives, they transform them. For our vital organs like hearts and lungs the impact of a ...

Matt is Director of Clinical Commissioning in the national specialised commissioning team at NHS England and is the senior ...

NHS England » Icatibant for treatment of moderate to severe acute swellings due to bradykinin-mediated angioedema with normal C1 inhibitor ...